November 12th 2024
The FDA cleared Novavax to start enrolling the planned phase 3 trial after a safety concern was found to be unrelated to the combination vaccine.
November 11th 2024
Insights on how to manage the "triple threat" of flu, RSV, and COVID-19 this season.
October 7th 2024
Less than one-quarter of people infected with influenza-associated severe acute respiratory illness were vaccinated, according to a new report.
September 30th 2024
Your daily dose of the clinical news you may have missed.
September 20th 2024
FluMist is the first influenza vaccine that does not have to be given by a health care professional.
What has COVID-19 Taught the US About Flu?
Vaccination against flu is the best protection from the infection according to 61% of US adults surveyed by NFID. How do the rest feel about the threat?
COVID-19 Hospitalization 23 Times Higher for Unvaccinated During Omicron Surge
The COVID-19 Omicron variant may cause milder disease than the Delta variant, but its rapid spread in Los Angeles County still singled out unvaccinated Angelinos.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of February 3, 2022
Data from the CDC on boosters and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of February 2, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of February 1, 2022
FDA Approves Second COVID-19 Vaccine, Moderna's Spikevax
Acting FDA Commissioner Janet Woodcock, MD, hopes the approval will help motivate more Americans to get vaccinated.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of January 31, 2022
Shingles Vaccination Significantly Reduced Dementia Risk in Large Retrospective Cohort Study
In persons who received both the HZV and Tdap vaccines, a significant 50% reduction in risk of dementia was seen, suggesting a nonspecific underlying association.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of January 27, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of January 26, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of January 24, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of January 21, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of January 19, 2022
“Nocebo” Effect Accounted for Nearly Two-thirds of COVID-19 Vaccine Adverse Events in New Analysis
Findings highlight the importance of educating the public about the potential for nocebo responses to help reduce worries about COVID-19 vaccination.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of January 18, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of January 14, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of January 13, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of January 11, 2022
Non-COVID-19 Vaccines Could Help Reduce the Burden of Pandemic, Suggests New Research
New research suggests heterologous vaccine interventions with low efficacy can significantly reduce COVID-19 cases, hospitalizations, and deaths.
Shingles Vaccine Recap: A Shingrix Primer for Primary Care
Herpes zoster vaccination rates in the US have ticked up only minimally since FDA approval of Shingrix. Brush up on the basics of the vaccine and pass it on to your patients.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of January 10, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of January 7, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of January 6, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of January 5, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of January 4, 2022
J&J Booster Found 85% Effective Against Severe Disease During Peak Omicron Case Load
The J&J booster shot given to health care workers in South Africa between mid-Nov and mid-Dec 2021 was highly effective against Omicron infection.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of January 3, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of December 20, 2021
The CDC Recommends Pfizer, Moderna COVID Vaccines over J&J
The CDC recommends against the J&J COVID-19 vaccine if Pfizer or Moderna mRNA shots are available while affirming that any COVID vaccine is better than none.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of December 16, 2021